DatasetName,COPA_S(1193) COPA_S(170) COPA_S(173) COPA_S(402) COPA_S(434) COPA_S(824) COPA_S(895) COPA_T(821),COPA_S(179) COPA_S(68) COPA_T(286) COPA_T(591)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,0.5038010537147667,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.5305650229648649,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5311718626694659,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5267256744525145,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,0.5478978209356552,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5215026227638052,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5295739932126593,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.537613984845513,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,0.5138415089330871,
EP2017_Untreated R#4 normalized log2 ratio,0.5350220608371126,
WZ2023_Pu_010_30min,0.5542977630632643,0.4078212518323443
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5469442547924974,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,0.40265296735937633
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5431831476584478,
JJ2018_Ratio H/L normalized___1,0.5394146689463079,
ZQ2022_C2,0.5517257152314374,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.5315851827148541,
AH2018_SILAC_MR_2_N,0.5491798988359189,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5811269682850025,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.539945387009797,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5596938207836819,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5658624858814764,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5225981872860684,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5529495286870917,0.38931928901361945
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.5347491205358323,
WZ2023_Pu_005_10min,0.5487758852742818,0.42236175505607887
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.5387244759100492,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5484048660533352,0.42071491221321455
AH2018_SILAC_MR_2_X,0.5402032104768137,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5003814114372247,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.5315105189780037,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.531349850495915,
JJ2018_Ratio M/L normalized pP3,0.532589645084502,0.3326212869960832
AH2018_SILAC_M_2_N,0.5344803435917572,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,0.5434091828693646,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5347314282174117,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.549303671878694,0.38060686346764333
CK2022_11 40-1,0.538518207964358,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5331755147710037,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5595376984499657,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.552177166728602,0.41827728434493017
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5331794804568056,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,0.512752918148857,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5461560710350555,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,0.5193731602477747,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.5581393800750182,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5343380229798687,
CK2022_1 200-1,0.5304351697339611,
PG2020_Intensity Mock_10h_D,0.5221381328903266,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5652507445630814,
RCJD2014_5min_1,0.5127437878252525,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5416118029788705,
PG2020_Intensity 2h_C,0.5066014125145957,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5200193899493873,
KBE2022_Log2_Ex_8_T,,0.4097748164524295
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.5256937381029332,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5493722147197969,
CK2022_3 40-1,0.5427772753183866,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.5520296068664559,
HH2022_Reporter intensity 8,,
ZQ2022_N2,0.5224787889211946,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5517563251682571,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5316676448835204,
YA2020_Reporter_intensity_Normal_No.1,0.5454063583237909,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,0.3787303507476675
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5792334598955485,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5693233894349017,
HS2024_8_I_T3,,
CF2017_EOC 3,0.5067234936999581,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,0.5758817507702602,
WZ2023_Pu_010_20min,0.5495577440286286,0.41511059467208145
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5426596610889884,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5287400146902462,
KS2014_Intensity N3,0.5724312446877909,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5287158137097023,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,0.5561467205786167,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,0.5395234524367263,
CF2017_OSE 27,0.5463656487588147,
KS2014_Intensity E15_2,0.5621222342374341,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5168433635669571,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,0.5212007306793327,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.5319811046429768,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5316678682897685,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5452516202044432,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5358505303116587,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.5364137962393887,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5285247904860042,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5372806327929306,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,0.5288297940616938,
CK2022_14 40-1,0.5371500937475421,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5303073060374189,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5431324557610484,
DL2023_control-1,,
AR2021_ALG 10 μM,0.539970822920872,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.528610664565611,
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5153372074549781,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.5373808664888332,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5258329681458039,
JW2021_After_3,0.5404683674520236,
GF2025_P8_Sph,0.5430759892303961,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.5299340693497707,
AH2018_SILAC_2_N,0.5338611554718187,
CK2022_11 200-1,0.5383370729927672,
CK2022_12 200-1,0.5389350056303531,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.5498099627670295,0.4207088742853316
AH2018_TMTMS2_2_N,0.5489631822531422,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5351856007629624,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5540831726026616,
KS2014_Intensity N4,0.5803543655227413,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5243989275017013,
CK2022_14 200-1,0.528707908021177,
SR2019_Hs578T_Biol_repl_1,0.5285788584829564,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5538881600809673,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5233849758760087,
JW2021_After_2,0.5457378899406745,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5242679332714452,
GF2025_P1_Adh,0.5223500090986721,
GF2025_P1_Sph,0.5373047352690201,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5441204184475807,0.4003349208471557
CF2017_EOC 1,0.5397840002859297,
CK2022_3 200-1,0.531370552531142,
AH2018_LFQ_IT_3_C,0.5324441289167905,
SR2019_Hs578T_Biol_repl_2,0.5143260951368088,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.538107120393209,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5261443683043008,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.5425759598351798,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5287464087918015,
JW2021_Before_2,0.5415330108469054,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5308567089437645,
AR2021_ALG 1 μM,0.5158901579734888,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5569022062467796,
CR2017_Ratio Replicate 3.2,0.5890948455346815,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5274804654542765,
CK2022_9 16-1,0.5246027132725337,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,0.5459036677257356,
CK2022_13 200-1,0.5301233731862521,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5352183908115778,
CK2022_16 16-1,0.5242972780068413,
FS2019_db/db3,0.5844389748712756,
CK2022_15 40-1,0.5372920975073339,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5518121296805929,0.4087432392669139
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5370075630489445,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5331319580398808,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5517181998203299,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.411552386679576
AH2018_LFQ_M_1_N,0.5461627164808922,
KBE2022_Log2_Ex_27_U,0.5370470768956062,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.538343848696252,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.5484123234897192,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5293298935384327,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5204561954446658,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.4170942590721046
SR2019_SKBR3_Biol_repl_3,0.5159847695326731,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5384987429371135,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5275151272363913,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,0.5445191609730223,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5336687922455389,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.4901150313378792,
AH2018_TMTMS2_3_X,0.5451069716516989,
GF2025_P3_Adh,0.5326333526611398,
SR2019_JIMT1_Biol_repl_2,0.5363252520090676,
AH2018_TMTMS2_1_C,0.5424583498511281,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5437091414572313,
KBE2022_Log2_Ex_19_U,,0.41133545042089603
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,0.5124889899606574,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.5542578609564441,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5605967676414069,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,0.5162912883659562,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,0.5447446626004028,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.5482287808550492,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.5441095668936194,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.5024488052507335,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5660948964453063,
HH2022_Reporter intensity 1,0.5379004644364389,
HH2022_Reporter intensity 2,0.5382052638212099,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5476795880289657,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5463286599673252,
SR2019_LM2_Biol_repl_3,0.522870707324969,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5038505838198973,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.5439191369314317,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5417375297946461,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5538872943570339,
KBE2022_Log2_Ex_9_U,0.5329572743535765,
AH2018_SILAC_M_3_N,0.532187069742738,
KBE2022_Log2_Ex_13_T,,0.40968581266128634
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,0.4952937129617364,
PG2020_Intensity Mock_10h_C,0.5218802303294803,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.5203178445221224,
RN2012_L12,0.526600182876149,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5313531712769389,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.5394926908235621,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5371827428295095,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.5427586592857865,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.52139063662462,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5364003236271916,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5559605807200955,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5239576373984738,
CK2022_5 200-1,0.523032004746871,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,0.5248126314303362,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.546624695803698,
AH2018_SILAC_MR_1_X,0.5470789820335904,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5366485005295415,
AH2018_SILAC_3_C,0.5313564873844896,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.5333529809055952,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,0.5163150384186296,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5437360136277802,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.5371510557626284,
JJ2018_Ratio M/L normalized pP2,0.5299389335981256,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.4917639189265991,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,0.5328837726170044,0.3346966599418829
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,0.5341028911183472,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.534273994642735,
AH2018_SILAC_IT_2_N,0.5284840220245239,
AH2018_SILAC_IT_1_X,0.5273617326279336,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.557698903879305,
WZ2023_Pe_025_20min,0.5511927640657793,0.38864839287874886
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5453771685816616,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5450842978815884,
RN2012_H06,0.5215830192365263,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5483294584584413,0.42853321450233145
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,0.5178474370964683
SR2019_JIMT1_Biol_repl_3,0.5486127551989695,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5499047300577673,
WZ2023_Su_025_10min,0.5516642413738906,0.4141717852573671
AH2018_LFQ_IT_4_X,0.5313488329324101,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5500712271140469,0.41344198949452615
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.5572137338930605,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5526158464895369,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5252285658751772,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5336967491553204,
LY2019_P7+,0.5605981763290924,
EP2017_Untreated R#1 normalized log2 ratio,0.5338009234079681,
RN2012_L10,0.4828331385754505,
PG2020_Intensity 4h_C,0.5173072512301369,
EP2017_Mitotic R#3 normalized log2 ratio,0.5617497532415602,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5361627316349064,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5279451986628395,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.5396016829226131,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.5345905425200124,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.49649342619382797,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,0.5107956245949249,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5279750480344043,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.570450440367003,
GF2025_P9_Sph,0.548397798377749,
CK2022_6 200-1,0.5258725005001734,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5514205585796997,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,0.5090113050531295,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,0.5292736952860726,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.526235840709848,
EP2017_Untreated R#3 normalized log2 ratio,0.5563414208981534,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5251795197830056,
KS2014_Intensity pY_C4,0.48903058707463215,
CR2017_Ratio Replicate 3.5,0.5580417249989487,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.5465914098831646,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5597211655652887,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5324582291004846,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.5305432145451339,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5477206127310016,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.53826999357636,
PG2020_Intensity CT_C,0.5250653948875305,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,0.5661905870988921,
KS2014_Intensity pY_PV4,0.5027564451035126,
KBE2022_Log2_Ex_39_U,0.5356511218576478,
EP2017_Untreated R#3 log2 ratio,0.5573990781461551,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5838742306689803,
HS2024_8_PD_T2,,
FS2019_Ctr2,0.5746530680638726,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,0.5121791831908886,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5385346128803798,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.579395491864837,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5383522615815843,
YA2020_Reporter_intensity_Normal_No.2,0.5454087183283319,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5395976123507538,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5483168583600252,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.40628423198386754
CK2022_2 16-1,0.5327042830754736,
RAM2015_Log2 B,0.5514801560511993,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.5292239459382981,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.5159903638601451,
WZ2023_Su_025_30min,0.5539904780330873,0.41033757603465737
AH2018_LFQ_4_N,0.5446296392721259,
CR2017_Ratio Replicate 1.2,0.5093978151574429,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.5369105914756045,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5165782249886273,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5360985468913773,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5525087523876305,
SR2019_Hs578T_Biol_repl_4,0.5162767645923967,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5779719905610567,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5512655595703011,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5474605554654431,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5297442556028629,
AH2018_LFQ_2_X,0.5429678580762904,
PG2020_Intensity 2h_B,0.5181608899168725,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5708711681954216,
GF2025_P3_Sph,0.5254352802930714,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5267595208470028,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5286193259981425,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.5494771507781345,
CR2017_Ratio Replicate 2.4,0.5802358598622624,
ZQ2022_N1,0.528387137158916,
LY2019_P6-,0.5174541702813018,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5616363287149674,
AH2018_LFQ_3_N,0.544884750262226,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.5477192337046549,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,0.41567054343636545
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.5267258610391505,0.37902959234425926
CK2022_7 40-1,0.536646722989752,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.522771880713183,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.5392866390990618,0.36806044009764793
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.549472254937972,0.42165040717636443
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.544610635326476,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,0.514079930020892,
CK2022_13 40-1,0.5367185968184481,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5223474231852674,
PG2020_Intensity 10h_D,0.5294628122751754,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5602020464127937,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5216251017056506,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5462038254484299,
AH2018_LFQ_M_4_C,0.5461230617511422,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,0.5371265192051959,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5380663611764911,
LY2019_P3-,0.5181195648871993,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5491197059891961,0.39874364381649097
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,0.5686133901503079,
WZ2023_Pu_025_20min,0.5500300564276223,0.4152989565429701
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5272126734900856,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5445836055252441,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5543630039836618,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5359344446954343,
LY2019_P8+,0.5607477862315775,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.5478891175528098,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,0.5173024461825749,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5482280213579716,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5334238966152699,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5315846492920411,
LY2019_P2-,0.5313882173415542,
AH2018_LFQ_IT_1_X,0.5290874449346205,
JJ2018_Ratio H/L normalized pP3___1,0.5266805665566388,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5466706754750614,0.4039002802282333
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5229409118893819,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5424975886413707,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,0.5037324160526938,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,0.5287332255378958,
KBE2022_Log2_Ex_36_U,0.535487813859078,
AH2018_TMTMS3_3_N,0.5530363692829424,
SR2019_HCC1419_Biol_repl_2,0.46564486503082897,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5468141987526556,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5631714496688816,
KBE2022_Log2_Ex_36_T,0.5358551344317947,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5491549161681495,0.4121229686160468
KS2014_Intensity C2,0.557232327004558,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5377249271173827,
CK2022_9 200-1,0.5374604171251692,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,0.5118867806551024
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5370734555911634,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5239510480386131,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5453152672241891,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,0.5217202279407479,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5530483146430227,
ZQ2022_C3,0.543590656853253,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5339473853898622,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5346929992092341,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5483072344898513,0.4149794311583443
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.5215767179376346,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5683437472302513,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.4972407992120459,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.5292653575196132,0.5035397802868146
AH2018_SILAC_MR_2_C,0.5468236593856585,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5476509387170725,
JJ2018_Ratio H/M normalized___1,0.528036542908002,
RCJD2014_15min_2,0.5307260265794564,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.5371177582901071,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5674470658915708,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.545387399754097,0.39788461898314653
KBE2022_Log2_Ex_29_U,0.5313367980616056,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.5460937262827112,
AH2018_LFQ_IT_4_N,0.5316633688721109,
CK2022_15 200-1,0.5298771425796022,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.5281350902784177,0.5124628421416486
JJ2018_Ratio M/L normalized pP3___1,0.5326079234480386,
KBE2022_Log2_Ex_34_T,0.5344498348622202,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,0.5180194271526051,
LY2019_P2+,0.5487380683622158,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5317298571917534,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5500193522634768,0.4204833385489631
RN2012_H01,0.5521623524652557,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5521248603165293,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.55416561680325,
KBE2022_Log2_Ex_44_U,0.5373377021243324,
WZ2023_Pe_010_20min,0.5474082615876903,0.4052187744053247
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5336014669612025,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5457550243593394,
KS2014_Intensity C1,0.5582877165744218,
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.531930646196282,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5331030162167968,
AH2018_SILAC_M_2_X,0.5325466913674586,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5375299740790174,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5498026120686041,0.41944041788928316
PG2020_Intensity 6h_C,0.5259071135276217,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.5493020844504585,
AH2018_LFQ_M_3_N,0.5478145032531581,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5433061715298739,
CK2022_15 16-1,0.5245885197384841,
CK2022_3 16-1,0.53510715084312,
LY2019_P4-,0.5574873683618234,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5452555190176537,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.547121151023961,
CK2022_10 16-1,0.5238145504306362,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5705105624673099,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.5381476907336767,
CF2017_EOC 2,0.5091827289200859,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5287277703879493,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.5307329610479058,
ZX2022_CB treated Replicate 1,0.5201450068322853,
BS2014_Log2(Ratio H/L normalized Rep_3),0.5397880445898462,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5378397088176676,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5423756430704791,
AR2021_L41 1 μM,0.528873586359928,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5446931165516656,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5218670560342241,
KS2014_Intensity C4,0.5366265094101335,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5391130478064833,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5139651888902714,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.546582952754435,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,0.516289561235065,
YA2020_Reporter_intensity_Cancer_No.2,0.5537571724244486,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.526534357495839,
WZ2023_Pu_025_10min,0.5483773213759844,0.4216941711400501
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.575790278796084,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,0.5242707415928214,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5350189473207208,
JJ2018_Ratio H/L normalized pP1___1,0.5435080952320397,
WZ2023_Pe_010_30min,0.5427761042675228,0.4052731556651197
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5338127998304959,
KS2014_Intensity C6,0.531921891707784,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5385690937525964,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5223434537735001,
JJ2018_Ratio H/M normalized pP1,0.5287154781404513,
CK2022_16 40-1,0.5377533939710866,
AH2018_SILAC_IT_2_C,0.5270193255461585,
CK2022_5 40-1,0.5374225973051425,
AH2018_LFQ_3_X,,
UK2020_UA_3,,
LY2019_P7-,0.5418012657685832,
GF2025_P5_Adh,0.5214877066874585,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,0.5189581917167932,
CR2017_Ratio Replicate 2.2,0.5245170095898142,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.524483760348595,
ZQ2022_C1,0.5426250192837034,
CR2017_Ratio Replicate 2.1,0.557331251401288,
PG2020_Intensity CT_B,0.5135437546735473,
JJ2018_Ratio M/L normalized___2,,0.3435713546109406
AH2018_SILAC_MR_1_N,0.5473803451355772,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,0.5385060518758517,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,0.5890290755340766,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5748923716635915,
AH2018_LFQ_3_C,0.5435763720209112,
JJ2018_Ratio M/L normalized pP3___2,,0.35109585830959344
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,0.5521863621779062,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5325903538321939,
RB2022_2_PreEndurance,,
JW2021_Before_1,0.5424639676415222,
KBE2022_Log2_Ex_25_T,0.5366991345594083,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.5329926215735954,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5246112201041294,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.41839631593707466
KS2014_Intensity pY_N1,0.5442156395862093,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5653546093973962,
AH2018_TMTMS2_1_X,0.5451161813634889,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5808497700333629,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,0.38904522003290504
CF2017_FTE 15,0.53506303910246,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.5291269250965723,
PG2020_Intensity 10h_B,0.5288595016977438,
AH2018_TMTMS3_1_X,0.5534821686653505,
CF2017_FTE 14,0.5347665413847043,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5295482434323705,
SR2019_HCC1419_Biol_repl_3,0.5036080519603572,
KBE2022_Log2_Ex_14_T,,0.3997095520478684
EP2017_Untreated R#2 normalized log2 ratio,0.5452895853061036,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5484262350810282,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5603933570746389,
AS2011_Ratio H/L Normalized RNAi_2_1,,
